Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Committee Legislation Roundup topic
No spam. Unsubscribe anytime.
Senate public health committee unanimously advances ambulance payments, step-therapy reform, PDMP audit authority and pharmacy licensing cleanup
Summary
The Senate Public Health, Welfare and Labor Committee voted to pass an ambulance payment bill, extend a Pan/PANDAS advisory council (linked to participation in a phase‑3 Octapharma study), approve step‑therapy reforms shifting rulemaking to the insurance department, authorize PDMP audits of original prescriptions, and remove duplicate pharmacist license endorsements for nursing‑home practice.
The Senate Public Health, Welfare and Labor Committee passed a slate of health-related bills by voice vote after brief presentations and limited committee questioning.
Ambulance payments: Senator Teague presented a bill expanding an "upper payment limit" mechanism to nonemergency runs by emergency ambulance providers to increase revenue for ambulance services. The bill includes an express exemption for Department of Human Services (DHS)‑contracted nonemergency transport providers. No public opposition was recorded; the committee moved and passed the bill.
Pan/PANDAS advisory council continuation: A sponsor asked the committee to extend an advisory council that faced a December sunset after COVID-related interruptions. The sponsor described partnerships with research institutions (including UAMS, UCLA and University of Wisconsin) and said a $30,000,000 Octapharma phase‑3 study will select about 94 adolescents nationally, with Arkansas afforded a role through the state's Center of Excellence. The committee approved continuation without objection.
Step‑therapy reform (Senate Bill 99): Committee members reviewed an amended bill intended to center step‑therapy rules on patient care. Key changes described by the sponsor include transferring rule‑making authority from DHS to the state insurance department, explicitly exempting dental/vision‑only plans and Medicaid, better defining utilization‑review organizations, requiring a multidisciplinary panel to develop clinical review criteria, and permitting peer‑reviewed medical literature to establish criteria with conflict‑of‑interest safeguards. Committee members asked whether ERISA/self‑insured large‑employer plans are covered; the sponsor said ERISA plans are excluded. Questions about selection and composition of the multidisciplinary panel were raised and the sponsor said the sponsor would provide definitions before floor consideration. The committee passed the bill.
PDMP audit authority (House Bill 1107): The bill would allow the Prescription Drug Monitoring Program (PDMP) to request copies of original paper or electronic prescriptions from pharmacies and, where applicable, from prescribers who dispense from their offices, to audit reported controlled‑substance dispensation data. Jamie Turpin, PDMP administrator, told the committee the authority would streamline corrections when data errors are reported. Kirk Lane, state drug director, testified the PDMP is an essential tool in the state's opioid response and urged passage. The committee approved the bill.
Pharmacy licensing cleanup (House Bill 1174): Sponsors said the bill removes two endorsement processes that create extra administrative steps for pharmacists practicing in nursing homes or serving as nursing‑home consultants and eliminates a redundant endorsement. John Kirtley, director of the Arkansas Board of Pharmacy, described the change as administrative cleanup; the committee passed the bill and adjourned.
Votes at a glance: Each bill recorded in committee was approved by voice vote. Where the transcript records specific motions, the record shows a motion by Senator Hester and a second by Senator Gilmore in at least one instance; other motions and seconds were not named in the hearing record.
The committee adjourned after completing the listed business.
